Risk factors

Marcum’s acquisition dominates the section, with integration, sanctions, controls, liabilities, and expected benefits creating concentrated execution risk.

Cryo-Cell International relies heavily on umbilical cord blood and tissue storage for revenue and faces risks related to clinical development, regulatory compliance, and a legal dispute with Duke University.

Cogent faces rapid debt and operational expansion following the Sprint Business acquisition.

CareDx depends heavily on Medicare reimbursement and sales of its AlloSure and AlloMap transplant testing solutions. Operations face intense competition from traditional biopsies and evolving diagnostic technologies. Regulatory oversight by the FDA and CLIA creates significant compliance burdens and potential operational hurdles.

Chemed's risk profile is dominated by heavy regulatory and reimbursement exposure in its VITAS hospice segment, alongside operational and labor challenges in Roto-Rooter.

Agriculture is now management’s primary focus, with Construction redesigned as a distinct division under new leadership.

The risk factors are dominated by commodity futures price volatility, tracking error from exchange limits, and complex partnership taxation.

Data access, privacy regulation, and technical restrictions threaten the data foundation supporting Criteo’s advertising platform.

New U.S. tariffs and broader trade restrictions are a prominent near-term threat to pricing, sourcing, markets, and customer agreements.

Dependence on key local employees and trusted community relationships drives funeral and cemetery market share.

Community Trust Bancorp operates primarily in regional markets across Kentucky, West Virginia, and Tennessee. Its risk profile is dominated by local economic dependency, regional lending concentrations, interest rate fluctuations, and heavy banking regulation.

Cytek Biosciences faces strong reliance on a limited number of core flow cytometry systems like Cytek Aurora. International expansion exposes the company to complex regulatory and trade policy risks. Academic and government institutional spending heavily dictates future revenue and research success.